Logos Global Management LP 13F Holdings
CIK 0001792126 · San Francisco, CA
As of Sep 30, 2025, Logos Global Management LP reported 56 positions worth
CIK 0001792126 · San Francisco, CA
As of Sep 30, 2025, Logos Global Management LP reported 56 positions worth
.1B in its SEC Form 13F filing.
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 2,750,000 | 28.4M | 11.51% |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 2,700,000 | $73.5M | 6.58% |
| AKERO THERAPEUTICS INC | AKRO | Healthcare | 1,200,000 | $57.0M | 5.11% |
| ARVINAS INC | ARVN | Healthcare | 5,575,000 | $47.5M | 4.26% |
| OCULAR THERAPEUTIX INC | OCUL | Healthcare | 3,250,000 | $38.0M | 3.41% |
| CIDARA THERAPEUTICS INC | CDTX | Healthcare | 375,000 | $35.9M | 3.22% |
| VERASTEM INC | VSTM | Healthcare | 4,050,000 | $35.8M | 3.21% |
| ABIVAX SA | ABVX | Healthcare | 415,000 | $35.2M | 3.16% |
| JANUX THERAPEUTICS INC | JANX | Healthcare | 1,435,000 | $35.1M | 3.14% |
| ERASCA INC | ERAS | Healthcare | 15,150,000 | $33.0M | 2.96% |
| MAZE THERAPEUTICS INC | MAZE | Healthcare | 1,227,300 | $31.8M | 2.85% |
| OLEMA PHARMACEUTICALS INC | OLMA | Healthcare | 3,208,875 | $31.4M | 2.82% |
| IMMUNOCORE HOLDINGS PLC | IMCR | Healthcare | 850,000 | $30.9M | 2.77% |
| DYNE THERAPEUTICS INC | DYN | Healthcare | 2,400,000 | $30.4M | 2.72% |
| DISC MEDICINE INC | IRON | Healthcare | 450,000 | $29.7M | 2.67% |
| DESIGN THERAPEUTICS INC | DSGN | Healthcare | 3,655,000 | $27.5M | 2.47% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | Healthcare | 200,000 | $26.4M | 2.36% |
| AVIDITY BIOSCIENCES INC | RNA | Healthcare | 600,000 | $26.1M | 2.34% |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 850,000 | $23.8M | 2.13% |
| APELLIS PHARMACEUTICALS INC | APLS | Healthcare | 1,000,000 | $22.6M | 2.03% |
| VAXCYTE INC | PCVX | Healthcare | 625,000 | $22.5M | 2.02% |
| RHYTHM PHARMACEUTICALS INC | RYTM | Healthcare | 200,000 | $20.2M | 1.81% |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 2,200,000 | $20.1M | 1.80% |
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 300,000 | 9.9M | 1.79% |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 1,450,000 | 9.7M | 1.77% |